GPCM
TFFP

Granite Point Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Granite Point Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,400
Closed -$2.02M – 185
2021
Q2 		$2.02M Hold
8,400
– – 0.07% 83
2021
Q1 		$2.85M Buy
+8,400
New +$3.42M 0.11% 70

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Granite Point Capital Management's TFFP Position: Q3 2021 in Review

Granite Point Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2021, closing a stake of 8,400 shares — an estimated $2.02M sold.

Granite Point Capital Management first reported a position in TFFP in Q1 2021 and held it in 2 quarters. The position peaked at $2.85M in Q1 2021. 54 funds tracked by Wall St. Rank hold TFFP as of Q3 2021.

  • Granite Point Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Granite Point Capital Management sold 8,400 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $2.02M.
  • Granite Point Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Granite Point Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $2.85M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Granite Point Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.